Works matching DE "COMPLEMENT (Immunology)"


Results: 2390
    1
    2
    3
    4

    Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial Open Access.

    Published in:
    Rheumatology, 2025, v. 64, n. 6, p. 3863, doi. 10.1093/rheumatology/keaf122
    By:
    • Geetha, Duvuru;
    • Pagnoux, Christian;
    • Sattui, Sebastian E;
    • Merkel, Peter A;
    • Weiner, Maria;
    • Draibe, Juliana;
    • Faguer, Stanislas;
    • Bray, Sarah;
    • Gurlin, Rachel E;
    • Balcells-Oliver, Monica;
    • Bruchfeld, Annette;
    • Jayne, David R;
    • Group, ADVOCATE Study
    Publication type:
    Article
    5
    6
    7

    Lymphadenopathy in systemic lupus erythematosus: no microbial trigger found by shotgun metagenomics in a retrospective study on 38 patients.

    Published in:
    Rheumatology, 2025, v. 64, n. 6, p. 3906, doi. 10.1093/rheumatology/keae578
    By:
    • Papo, Matthias;
    • Cappy, Pierre;
    • Degachi, Alexandre;
    • Woerther, Paul-Louis;
    • Saal, Caroline;
    • Charlotte, Frédéric;
    • Brocheriou, Isabelle;
    • Lhote, Raphaël;
    • Trefond, Ludovic;
    • Hié, Miguel;
    • Haroche, Julien;
    • Pha, Micheline;
    • Cohen-Aubart, Fleur;
    • Mathian, Alexis;
    • Rodriguez, Christophe;
    • Amoura, Zahir
    Publication type:
    Article
    8
    9
    10
    11

    Exploring intracellular anti-mycobacterium activity of lactoferricin-loaded niosomes: proteomics insights into Immunomodulation.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-04673-2
    By:
    • Sangboonruang, Sirikwan;
    • Semakul, Natthawat;
    • Poomanee, Worrapan;
    • Thavanapong, Thasang;
    • Roytrakul, Sittiruk;
    • Charoenlappanit, Sawanya;
    • Thaisakun, Siriwan;
    • Khantipongse, Jiaranai;
    • Netirat, Nathiprada;
    • Tongsong, Apiwadee;
    • Wattananandkul, Usanee;
    • Intorasoot, Sorasak;
    • Phunpae, Ponrut;
    • Tragoolpua, Khajornsak
    Publication type:
    Article
    12
    13
    14
    15
    16

    A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS).

    Published in:
    Trials, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s13063-025-08895-7
    By:
    • Ostermann, Marlies;
    • Corteville, David C.;
    • Doi, Kent;
    • Koyner, Jay L.;
    • Lamy, Andre;
    • Li, Gerry;
    • Solinsky, Christine M.;
    • Winterberg, Pamela D.;
    • Smith, William T.;
    • Mehta, Ravindra L.;
    • Murray, Patrick T.;
    • Shaw, Andrew D.;
    • Zarbock, Alexander;
    • Engelman, Daniel T.
    Publication type:
    Article
    17
    18
    19
    20

    CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD.

    Published in:
    2006
    By:
    • Magnusson, Kristinn P.;
    • Duan, Shan;
    • Sigurdsson, Haraldur;
    • Petursson, Hjorvar;
    • Zhenglin Yang;
    • Yu Zhao;
    • Bernstein, Paul S.;
    • Ge, Jian;
    • Jonasson, Fridbert;
    • Stefansson, Einar;
    • Helgadottir, Gudleif;
    • Zabriskie, Norman A.;
    • Jonsson, Thorlakur;
    • Björnsson, Asgeir;
    • Thorlacius, Theodora;
    • Jonsson, Palmi V.;
    • Thorleifsson, Gudmar;
    • Kong, Augustine;
    • Stefansson, Hreinn;
    • Kang Zhang
    Publication type:
    journal article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    The dark side of C5a in sepsis.

    Published in:
    Nature Reviews Immunology, 2004, v. 4, n. 2, p. 133, doi. 10.1038/nri1269
    By:
    • Ward, Peter A.
    Publication type:
    Article
    48
    49
    50